Literature DB >> 22820134

Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations.

Amrit Paudel1, Zelalem Ayenew Worku, Joke Meeus, Sandra Guns, Guy Van den Mooter.   

Abstract

Spray drying is an efficient technology for solid dispersion manufacturing since it allows extreme rapid solvent evaporation leading to fast transformation of an API-carrier solution to solid API-carrier particles. Solvent evaporation kinetics certainly contribute to formation of amorphous solid dispersions, but also other factors like the interplay between the API, carrier and solvent, the solution state of the API, formulation parameters (e.g. feed concentration or solvent type) and process parameters (e.g. drying gas flow rate or solution spray rate) will influence the final physical structure of the obtained solid dispersion particles. This review presents an overview of the interplay between manufacturing process, formulation parameters, physical structure, and performance of the solid dispersions with respect to stability and drug release characteristics.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amorphous; Formulation; Poorly soluble drugs; Process parameters; Solid dispersions; Spray drying

Mesh:

Substances:

Year:  2012        PMID: 22820134     DOI: 10.1016/j.ijpharm.2012.07.015

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  59 in total

Review 1.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

2.  Development of a Control Strategy for Benzene Impurity in HPMCAS-Stabilized Spray-Dried Dispersion Drug Products Using a Science-Based and Risk-Based Approach.

Authors:  Hongfei Yue; Sarah J Nicholson; Joel D Young; Daniel Hsieh; Rodney J Ketner; Robert G Hall; Jeremy Sackett; Elizabeth C Banks; John A Castoro; Michael E Randazzo
Journal:  Pharm Res       Date:  2015-02-28       Impact factor: 4.200

3.  The secondary drying and the fate of organic solvents for spray dried dispersion drug product.

Authors:  Daniel S Hsieh; Hongfei Yue; Sarah J Nicholson; Daniel Roberts; Richard Schild; John F Gamble; Mark Lindrud
Journal:  Pharm Res       Date:  2014-12-17       Impact factor: 4.200

4.  Combination of (M)DSC and surface analysis to study the phase behaviour and drug distribution of ternary solid dispersions.

Authors:  Joke Meeus; David J Scurr; Xinyong Chen; Katie Amssoms; Martyn C Davies; Clive J Roberts; Guy Van den Mooter
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

5.  Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.

Authors:  Anjali Agrawal; Mayur Dudhedia; Weibin Deng; Kevin Shepard; Li Zhong; Edward Povilaitis; Ewa Zimny
Journal:  AAPS PharmSciTech       Date:  2016-01-12       Impact factor: 3.246

Review 6.  Use of Spray-Dried Dispersions in Early Pharmaceutical Development: Theoretical and Practical Challenges.

Authors:  Jinjiang Li; Dhaval Patel; George Wang
Journal:  AAPS J       Date:  2016-11-28       Impact factor: 4.009

7.  Surface Enrichment and Depletion of the Active Ingredient in Spray Dried Amorphous Solid Dispersions.

Authors:  Zhen Chen; Kuan Yang; Chengbin Huang; Alan Zhu; Lian Yu; Feng Qian
Journal:  Pharm Res       Date:  2018-01-29       Impact factor: 4.200

8.  Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.

Authors:  Justin S LaFountaine; Leena Kumari Prasad; Chris Brough; Dave A Miller; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-10-13       Impact factor: 3.246

9.  Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus.

Authors:  Sugandha Saboo; Ebenezer Tumban; Julianne Peabody; Denis Wafula; David S Peabody; Bryce Chackerian; Pavan Muttil
Journal:  Mol Pharm       Date:  2016-04-11       Impact factor: 4.939

10.  Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: Effect of formulation and process parameters for a low glass transition temperature drug.

Authors:  Venkata Raman Kallakunta; Sandeep Sarabu; Suresh Bandari; Amol Batra; Vivian Bi; Thomas Durig; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-11-18       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.